Pfizer And Biontech
-
{
- All
- News
- Videos
-
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab
"A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months," they said.
-
Pfizer-BioNTech To Test Combined Vaccine For Covid, Flu
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
-
Pfizer Submits Initial Data For Covid Vaccine Booster Authorization
Pfizer Inc and its German partner BioNTech SE have submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a booster dose of their COVID-19 vaccine, the drugmakers said on Monday.
-
Pfizer, BioNTech To Seek Authorization For Third Dose Of COVID-19 Vaccine
Pfizer and BioNTech announced Thursday they would seek authorization for a third dose of their Covid-19 vaccine.
-
Pfizer Estimates $15 Billion In 2021 Sales For COVID-19 Vaccine
Sales of the Covid-19 vaccine developed by Pfizer and BioNTech could reach up to $15 billion in 2021 and go higher if Pfizer signs additional supply contracts, Pfizer said Tuesday.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Pfizer, US Seal 100 Million Covid-19 Vaccine Deal With Additional 70 Million Due By June
Covid-19 vaccine: Pfizer said last week it could need the US government to help it secure some components needed to make the vaccine
-
UK Warns Against Pfizer Vaccine For Those With Serious Allergies After 2 Reactions
Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported adverse effects on the first day of rollout.
-
India May Not Get Pfizer Covid Vaccine, Cleared By UK, Anytime Soon: Sources
The coronavirus vaccine developed by American pharma giant Pfizer, which was cleared by the United Kingdom Wednesday and will be rolled out to the public early next week, is unlikely to be available in India at this time, sources have told NDTV
-
BioNTech/Pfizer Apply For EU Approval Of Covid-19 Vaccine
Germany's BioNTech and its US partner Pfizer said on Tuesday they had applied for EU regulatory approval for their Covid-19 vaccine, raising hopes that the first jabs could be administered in December.
-
Daily Texts For First Week For Those Who Get Pfizer Vaccine
Regulatory authorities are gearing up for a deluge in people reporting side effects when the new covid-19 vaccines go into use. Even as vaccines like the one from Pfizer and BioNTech reach safety milestones and look set for regulatory approval, managing the reporting and follow-up of what are known as adverse drug reactions will be critical to keep...
-
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab
"A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months," they said.
-
Pfizer-BioNTech To Test Combined Vaccine For Covid, Flu
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
-
Pfizer Submits Initial Data For Covid Vaccine Booster Authorization
Pfizer Inc and its German partner BioNTech SE have submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a booster dose of their COVID-19 vaccine, the drugmakers said on Monday.
-
Pfizer, BioNTech To Seek Authorization For Third Dose Of COVID-19 Vaccine
Pfizer and BioNTech announced Thursday they would seek authorization for a third dose of their Covid-19 vaccine.
-
Pfizer Estimates $15 Billion In 2021 Sales For COVID-19 Vaccine
Sales of the Covid-19 vaccine developed by Pfizer and BioNTech could reach up to $15 billion in 2021 and go higher if Pfizer signs additional supply contracts, Pfizer said Tuesday.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Pfizer, US Seal 100 Million Covid-19 Vaccine Deal With Additional 70 Million Due By June
Covid-19 vaccine: Pfizer said last week it could need the US government to help it secure some components needed to make the vaccine
-
UK Warns Against Pfizer Vaccine For Those With Serious Allergies After 2 Reactions
Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported adverse effects on the first day of rollout.
-
India May Not Get Pfizer Covid Vaccine, Cleared By UK, Anytime Soon: Sources
The coronavirus vaccine developed by American pharma giant Pfizer, which was cleared by the United Kingdom Wednesday and will be rolled out to the public early next week, is unlikely to be available in India at this time, sources have told NDTV
-
BioNTech/Pfizer Apply For EU Approval Of Covid-19 Vaccine
Germany's BioNTech and its US partner Pfizer said on Tuesday they had applied for EU regulatory approval for their Covid-19 vaccine, raising hopes that the first jabs could be administered in December.
-
Daily Texts For First Week For Those Who Get Pfizer Vaccine
Regulatory authorities are gearing up for a deluge in people reporting side effects when the new covid-19 vaccines go into use. Even as vaccines like the one from Pfizer and BioNTech reach safety milestones and look set for regulatory approval, managing the reporting and follow-up of what are known as adverse drug reactions will be critical to keep...
